COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 929: Articles 9281-9290  | Next

The Investigation of Pulmonary Abnormalities using Hyperpolarised Xenon Magnetic Resonance Imaging in Patients with Long-COVID.
Grist, J. T., Collier, G. J., Walters, H., Chen, M., Abu Eid, G., Laws, A., Matthews, V., Jacob, K., Cross, S., Eves, A., Durrant, M., Mcintyre, A., Thompson, R., Schulte, R. F., Raman, B., Robbins, P. A., Wild, J. M., Fraser, E., Gleeson, F.
10.1101/2022.02.01.22269999 — Posted: 2022-02-02
Zero-COVID Policies: Melbourne's 112-Day Hard Lockdown Experiment Harmed Mostly Mothers
Schurer, S., Atalay, K., Glozier, N., Vera-Toscano, E., Wooden, M.
10.1101/2022.01.30.22270130 — Posted: 2022-02-02
The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies
Ward, J. D., Cornaby, C., Kato, T., Gilmore, R. C., Bunch, D. O., Miller, M. B., Boucher, R. C., Schmitz, J. L., Askin, F. A., Scanga, L. R.
10.1101/2022.02.01.22270179 — Posted: 2022-02-02
Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohort
Navaratnam, A. M. D., Shrotri, M., Nguyen, V., Braithwaite, I., Beale, S., Byrne, T. E., Fong, W. L. E., Fragaszy, E., Geismar, C., Hoskins, S., Kovar, J., Patel, P., Yavlinsky, A., Aryee, A., Rodger, A., Hayward, A. C., Aldridge, R. W.
10.1101/2022.02.01.22270269 — Posted: 2022-02-02
Toward an atomistic model of SARS-CoV-2
Wang, D., Li, J., Wang, L., Cao, Y., Li, S., Song, C.
10.1101/2022.01.31.478415 — Posted: 2022-02-02
ImmunoTyper-SR: A Novel Computational Approach for Genotyping Immunoglobulin Heavy Chain Variable Genes using Short Read Data
Ford, M., Hari, A., Rodriguez, O., Xu, J., Lack, J., Oguz, C., Zhang, Y., Weber, S., Magliocco, M., Barnett, J., Xirasagar, S., Samuel, S., Imberti, L., Bonfanti, P., Biondi, A., Dalgard, C., Chanock, S., Rosen, L., Holland, S., Su, H., Notarangelo, L., Vishkin, U., Watson, C., Sahinalp, C.
10.1101/2022.01.31.478564 — Posted: 2022-02-02
High Rates of Rapid Antigen Test Positivity After 5 Days of Isolation for COVID-19
Landon, E. M., Bartlett, A. H., Marrs, R., Guenette, C., Weber, S. G., Mina, M. J.
10.1101/2022.02.01.22269931 — Posted: 2022-02-02 Discussion: Onsite
The public views of and reactions to the COVID-19 pandemic in England- a qualitative study with diverse ethnicities
McNulty, C., Sides, E., Thomas, A., Kamal, A., Syeda, R., Kaissi, A., Lecky, D., Patel, M., Campos-Matos, I., Shukla, R., Brown, C., Pareek, M., Sollars, L., Nellums, L. B., Greenway, J., Jones, L. F.
10.1101/2022.02.02.22270238 — Posted: 2022-02-02
Neutralization profile of Omicron variant convalescent individuals
Roessler, A., Knabl, L., von Laer, D., Kimpel, J.
10.1101/2022.02.01.22270263 — Posted: 2022-02-02 Discussion: Onsite
Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters
Sanchez-Montalva, A., Alvarez-Sierra, D., Martinez-Gallo, M., Perurena-Prieto, J., Arrese-Munoz, I., Ruiz-Rodriguez, J. C., Espinosa-Pereiro, J., Bosch-Nicolau, P., Martinez-Gomez, X., Anton, A., Martinez-Valle, F., Riveiro-Barciela, M., Rodriguez-Frias, F., Castellano-Escuder, P., Poyato-Canton, E., Bas-Minguet, J., Martinez-Caceres, E. M., Sanchez-Pla, A., Zurera-Egea, C., Teniente-Serra, A., Hernandez-Gonzalez, M., Pujol Borrell, R.
10.1101/2022.01.29.22270016 — Posted: 2022-02-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).